Verition Fund Management
ASND icon

Verition Fund Management’s Ascendis Pharma A/S ASND Stock Holding History

Verition Fund Management’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-7,420
Closed -$1.58M – 2307
2025
Q4 		$1.58M Buy
+7,420
New +$1.53M 0.01% 1808
2025
Q3 		– Sell
-15,324
Closed -$2.64M – 3747
2025
Q2 		$2.64M Buy
+15,324
New +$2.5M 0.02% 1719
2025
Q1 		– Sell
-4,300
Closed -$592K – 3320
2024
Q4 		$592K Buy
+4,300
New +$565K ﹤0.01% 2373
2023
Q4 		– Sell
-87,112
Closed -$8.16M – 2333
2023
Q3 		$8.16M Sell
87,112
-22,946
-21% -$2.15M 0.11% 277
2023
Q2 		$9.82M Buy
+110,058
New +$9.58M 0.15% 204

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return